PI3K/Akt signaling has been shown to be activated in a variety of cancers and activated Akt acts to phosphorylate Bad and Caspase-9 or activate NF-κB pathway to promote the resistance of cancer cells to apoptosis [21–24]. The gene discussed is CASP9; the disease is cancer.